Balance Sheet

v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Jun. 30, 2025
Current assets    
Cash $ 2,237,223 $ 2,975,150
Accounts receivable, net 284,261 157,515
Inventory, net 1,035,680 1,152,870
Due from VitaMedica transition 471,380 228,017
Prepaid expenses and other receivables 1,480,227 350,836
Current digital assets at fair value 212,832,396 49,913,655
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Total current assets 220,341,167 56,778,043
Property and equipment, net 1,931,498 2,052,573
Intangible assets, net 143,923 163,113
Goodwill 848,854 848,854
Deferred tax asset 5,948,858 5,948,858
Investment in digital company 750,000 0
Digital assets at fair value, net of current 187,993,435 56,083,525
Other assets 200,690 192,123
Right-of-use asset, net 1,569,742 1,739,755
Total other assets 199,387,000 67,028,801
Total assets 419,728,167 123,806,844
Current liabilities    
Accounts payable 2,184,897 1,039,370
Accrued compensation 3,176,969 3,470,296
Deferred revenue 51,347 13,155
Accrued liabilities 947,076 356,064
Accrued interest 1,545,481 792,449
Acquisition payable 260,652 260,652
Current portion of promissory notes 560,000 560,000
Short-term treasury debt 50,000,000 20,000,000
Current portion of Cygnet subsidiary notes payable 5,380,910 5,380,910
Current portion of operating lease payable 521,702 691,010
Total current liabilities 64,629,034 32,563,906
Operating lease payable, net of current portion 1,145,439 1,145,440
Convertible notes payable 143,161,862 0
Total long-term liabilities 144,307,301 1,145,440
Stockholders' equity    
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 and 150,000 shares issued and outstanding, respectively 2 2
Common stock, $0.00001 par value, 300,000,000 shares authorized, and 58,893,261 and 38,270,571 shares issued and outstanding, respectively 589 383
Additional paid in capital 204,586,941 150,640,935
Retain earnings (accumulated deficit) 6,204,300 (60,543,822)
Total stockholders' equity 210,791,832 90,097,498
Total liabilities and stockholders' equity $ 419,728,167 $ 123,806,844

Source

PDF HTML
ZIP